Akturk, G., et al.  CIMAC-CIDC tissue imaging harmonization. J Clin Oncol (2020);38:15s (suppl; abstr 3125) https://ascopubs.org/doi/abs/10.1200/JCO.2020.38.15_suppl.3125

Akturk G, et al.  Multiplex Tissue Imaging Harmonization: A Multicenter Experience from CIMAC-CIDC Immuno-Oncology Biomarkers Network.  Clin Cancer Res. 2021 Jul 12;clincanres.CCR-21-2051-E.2021. doi: 10.1158/1078-0432.CCR-21-2051.

Akturk, G., Sweeney, R., Remark, R., Merad, M., & Gnjatic, S. (2020). Multiplexed Immunohistochemical Consecutive Staining on Single Slide (MICSSS): Multiplexed Chromogenic IHC Assay for High-Dimensional Tissue Analysis. Methods in molecular biology (Clifton, N.J.)2055, 497–519. https://doi.org/10.1007/978-1-4939-9773-2_23

Alatrash, G., Qiao, N., Zhang, M., Zope, M., Perakis, A. A., Sukhumalchandra, P., Philips, A. V., Garber, H. R., Kerros, C., St John, L. S., Khouri, M. R., Khong, H., Clise-Dwyer, K., Miller, L. P., Wolpe, S., Overwijk, W. W., Molldrem, J. J., Ma, Q., Shpall, E. J., & Mittendorf, E. A. (2019). Fucosylation Enhances the Efficacy of Adoptively Transferred Antigen-Specific Cytotoxic T Lymphocytes. Clinical cancer research : an official journal of the American Association for Cancer Research25(8), 2610–2620. https://doi.org/10.1158/1078-0432.CCR-18-1527

Bendall, S. C., Davis, K. L., Amir, e., Tadmor, M. D., Simonds, E. F., Chen, T. J., Shenfeld, D. K., Nolan, G. P., & Pe’er, D. (2014). Single-cell trajectory detection uncovers progression and regulatory coordination in human B cell development. Cell157(3), 714–725. https://doi.org/10.1016/j.cell.2014.04.005

Braun, D. A., Hou, Y., Bakouny, Z., Ficial, M., Sant’ Angelo, M., Forman, J., Ross-Macdonald, P., Berger, A. C., Jegede, O. A., Elagina, L., Steinharter, J., Sun, M., Wind-Rotolo, M., Pignon, J. C., Cherniack, A. D., Lichtenstein, L., Neuberg, D., Catalano, P., Freeman, G. J., Sharpe, A. H., … Choueiri, T. K. (2020). Interplay of somatic alterations and immune infiltration modulates response to PD-1 blockade in advanced clear cell renal cell carcinoma. Nature medicine26(6), 909–918. https://doi.org/10.1038/s41591-020-0839-y

Butterfield, L.H., et al. SITC 2018 Workshop Report: Immuno-Oncology Biomarkers: State of the Art. J Immunotherapy Cancer (2018);138. https://doi.org/10.1186/s40425-018-0453-4

Cader, F. Z., Schackmann, R., Hu, X., Wienand, K., Redd, R., Chapuy, B., Ouyang, J., Paul, N., Gjini, E., Lipschitz, M., Armand, P., Wu, D., Fromm, J. R., Neuberg, D., Liu, X. S., Rodig, S. J., & Shipp, M. A. (2018). Mass cytometry of Hodgkin lymphoma reveals a CD4+ regulatory T-cell-rich and exhausted T-effector microenvironment. Blood132(8), 825–836. https://doi.org/10.1182/blood-2018-04-843714

Carbonell G, et al. Quantitative chest CT combined with plasma cytokines predict outcomes in COVID-19 patients. medRxiv [Preprint]. 2021 Oct 14:2021.10.11.21264709. doi: 10.1101/2021.10.11.21264709. PMID: 34671777; PMCID: PMC8528085.

Chen HX, et al. Network for Biomarker Immunoprofiling for Cancer Immunotherapy: Cancer Immune Monitoring and Analysis Centers and Cancer Immunologic Data Commons (CIMAC-CIDC). Clin Cancer Res 2021; OnlineFirst. doi: 10.1158/1078-0432.CCR-20-3241.

Clifton, G. T., Hale, D., Vreeland, T. J., Hickerson, A. T., Litton, J. K., Alatrash, G., Murthy, R. K., Qiao, N., Philips, A. V., Lukas, J. J., Holmes, J. P., Peoples, G. E., & Mittendorf, E. A. (2020). Results of a Randomized Phase IIb Trial of Nelipepimut-S + Trastuzumab versus Trastuzumab to Prevent Recurrences in Patients with High-Risk HER2 Low-Expressing Breast Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research26(11), 2515–2523. https://doi.org/10.1158/1078-0432.CCR-19-2741

Del Valle, D. M., Kim-Schulze, S., Huang, H. H., Beckmann, N. D., Nirenberg, S., Wang, B., Lavin, Y., Swartz, T. H., Madduri, D., Stock, A., Marron, T. U., Xie, H., Patel, M., Tuballes, K., Van Oekelen, O., Rahman, A., Kovatch, P., Aberg, J. A., Schadt, E., Jagannath, S., … Gnjatic, S. (2020). An inflammatory cytokine signature predicts COVID-19 severity and survival. Nature medicine26(10), 1636–1643. https://doi.org/10.1038/s41591-020-1051-9

Dobry, A. S., Zogg, C. K., Hodi, F. S., Smith, T. R., Ott, P. A., & Iorgulescu, J. B. (2018). Management of metastatic melanoma: improved survival in a national cohort following the approvals of checkpoint blockade immunotherapies and targeted therapies. Cancer immunology, immunotherapy : CII67(12), 1833–1844. https://doi.org/10.1007/s00262-018-2241-x

Francisco-Cruz A, et al. Multiplex Immunofluorescence Assays. Methods Mol Biol (2020);2055:467-495.  PMID: 31502166. In: Thurin M, Cesano A, Marincola FM (Eds.). Biomarkers for Immunotherapy of Cancer: Methods and Protocols. Springer Nature.

Fu, J., Li, K., Zhang, W., Wan, C., Zhang, J., Jiang, P., & Liu, X. S. (2020). Large-scale public data reuse to model immunotherapy response and resistance. Genome medicine12(1), 21. https://doi.org/10.1186/s13073-020-0721-z

Garcia J, et al. Clinical and Immunologic Activity of Ipilimumab Following Decitabine Priming in Post-Allogeneic Transplant and Transplant-Naïve Patients with Relapsed or Refractory Myelodysplastic Syndromes and Acute Myeloid Leukemia: A Multi-Center Phase 1, Two-Arm, Dose-Escalation Study. Blood (2019) 134 (Supplement 1): 2015.  https://doi.org/10.1182/blood-2019-126238

Gentles, A. J., Hui, A. B., Feng, W., Azizi, A., Nair, R. V., Bouchard, G., Knowles, D. A., Yu, A., Jeong, Y., Bejnood, A., Forgó, E., Varma, S., Xu, Y., Kuong, A., Nair, V. S., West, R., van de Rijn, M., Hoang, C. D., Diehn, M., & Plevritis, S. K. (2020). A human lung tumor microenvironment interactome identifies clinically relevant cell-type cross-talk. Genome biology21(1), 107. https://doi.org/10.1186/s13059-020-02019-x

Glass, D. R., Tsai, A. G., Oliveria, J. P., Hartmann, F. J., Kimmey, S. C., Calderon, A. A., Borges, L., Glass, M. C., Wagar, L. E., Davis, M. M., & Bendall, S. C. (2020). An Integrated Multi-omic Single-Cell Atlas of Human B Cell Identity. Immunity53(1), 217–232.e5. https://doi.org/10.1016/j.immuni.2020.06.013

Good, Z., Borges, L., Vivanco Gonzalez, N., Sahaf, B., Samusik, N., Tibshirani, R., Nolan, G. P., & Bendall, S. C. (2019). Proliferation tracing with single-cell mass cytometry optimizes generation of stem cell memory-like T cells. Nature biotechnology37(3), 259–266. https://doi.org/10.1038/s41587-019-0033-2

Gruber, C. N., Patel, R. S., Trachtman, R., Lepow, L., Amanat, F., Krammer, F., Wilson, K. M., Onel, K., Geanon, D., Tuballes, K., Patel, M., Mouskas, K., O’Donnell, T., Merritt, E., Simons, N. W., Barcessat, V., Del Valle, D. M., Udondem, S., Kang, G., Gangadharan, S., … Bogunovic, D. (2020). Mapping Systemic Inflammation and Antibody Responses in Multisystem Inflammatory Syndrome in Children (MIS-C). Cell183(4), 982–995.e14. https://doi.org/10.1016/j.cell.2020.09.034

Gruber, C., Patel, R., Trachman, R., Lepow, L., Amanat, F., Krammer, F., Wilson, K. M., Onel, K., Geanon, D., Tuballes, K., Patel, M., Mouskas, K., Simons, N., Barcessat, V., Valle, D. D., Udondem, S., Kang, G., Gangadharan, S., Ofori-Amanfo, G., Rahman, A., … Bogunovic, D. (2020). Mapping Systemic Inflammation and Antibody Responses in Multisystem Inflammatory Syndrome in Children (MIS-C). medRxiv : the preprint server for health sciences, 2020.07.04.20142752. https://doi.org/10.1101/2020.07.04.20142752

Hartmann, F. J., Babdor, J., Gherardini, P. F., Amir, E. D., Jones, K., Sahaf, B., Marquez, D. M., Krutzik, P., O’Donnell, E., Sigal, N., Maecker, H. T., Meyer, E., Spitzer, M. H., & Bendall, S. C. (2019). Comprehensive Immune Monitoring of Clinical Trials to Advance Human Immunotherapy. Cell reports28(3), 819–831.e4. https://doi.org/10.1016/j.celrep.2019.06.049

Hartmann, F. J., & Bendall, S. C. (2020). Immune monitoring using mass cytometry and related high-dimensional imaging approaches. Nature reviews. Rheumatology16(2), 87–99. https://doi.org/10.1038/s41584-019-0338-z

Hartmann, F. J., Mrdjen, D., McCaffrey, E., Glass, D. R., Greenwald, N. F., Bharadwaj, A., Khair, Z., Verberk, S., Baranski, A., Baskar, R., Graf, W., Van Valen, D., Van den Bossche, J., Angelo, M., & Bendall, S. C. (2020). Single-cell metabolic profiling of human cytotoxic T cells. Nature biotechnology, 10.1038/s41587-020-0651-8. Advance online publication. https://doi.org/10.1038/s41587-020-0651-8

Hartmann, F. J., Simonds, E. F., & Bendall, S. C. (2018). A Universal Live Cell Barcoding-Platform for Multiplexed Human Single Cell Analysis. Scientific reports8(1), 10770. https://doi.org/10.1038/s41598-018-28791-2

Hartmann, F. J., Simonds, E. F., Vivanco, N., Bruce, T., Borges, L., Nolan, G. P., Spitzer, M. H., & Bendall, S. C. (2019). Scalable Conjugation and Characterization of Immunoglobulins with Stable Mass Isotope Reporters for Single-Cell Mass Cytometry Analysis. Methods in molecular biology (Clifton, N.J.)1989, 55–81. https://doi.org/10.1007/978-1-4939-9454-0_5

Hu, X., Zhang, J., Wang, J., Fu, J., Li, T., Zheng, X., Wang, B., Gu, S., Jiang, P., Fan, J., Ying, X., Zhang, J., Carroll, M. C., Wucherpfennig, K. W., Hacohen, N., Zhang, F., Zhang, P., Liu, J. S., Li, B., & Liu, X. S. (2019). Landscape of B cell immunity and related immune evasion in human cancers. Nature genetics51(3), 560–567. https://doi.org/10.1038/s41588-018-0339-x

Jiang, P., Gu, S., Pan, D., Fu, J., Sahu, A., Hu, X., Li, Z., Traugh, N., Bu, X., Li, B., Liu, J., Freeman, G. J., Brown, M. A., Wucherpfennig, K. W., & Liu, X. S. (2018). Signatures of T cell dysfunction and exclusion predict cancer immunotherapy response. Nature medicine24(10), 1550–1558. https://doi.org/10.1038/s41591-018-0136-1

Jiang, P., Sellers, W. R., & Liu, X. S. (2018). Big Data Approaches for Modeling Response and Resistance to Cancer Drugs. Annual review of biomedical data science1, 1–27. https://doi.org/10.1146/annurev-biodatasci-080917-013350

Keren, L., Bosse, M., Marquez, D., Angoshtari, R., Jain, S., Varma, S., Yang, S. R., Kurian, A., Van Valen, D., West, R., Bendall, S. C., & Angelo, M. (2018). A Structured Tumor-Immune Microenvironment in Triple Negative Breast Cancer Revealed by Multiplexed Ion Beam Imaging. Cell174(6), 1373–1387.e19. https://doi.org/10.1016/j.cell.2018.08.039

Keren, L., Bosse, M., Thompson, S., Risom, T., Vijayaragavan, K., McCaffrey, E., Marquez, D., Angoshtari, R., Greenwald, N. F., Fienberg, H., Wang, J., Kambham, N., Kirkwood, D., Nolan, G., Montine, T. J., Galli, S. J., West, R., Bendall, S. C., & Angelo, M. (2019). MIBI-TOF: A multiplexed imaging platform relates cellular phenotypes and tissue structure. Science advances5(10), eaax5851. https://doi.org/10.1126/sciadv.aax5851

Kimmey, S. C., Borges, L., Baskar, R., & Bendall, S. C. (2019). Parallel analysis of tri-molecular biosynthesis with cell identity and function in single cells. Nature communications10(1), 1185. https://doi.org/10.1038/s41467-019-09128-7

Lee, B. H., Kelly, G., Bradford, S., Davila, M., Guo, X. V., Amir, E. D., Thrash, E. M., Solga, M. D., Lannigan, J., Sellers, B., Candia, J., Tsang, J., Montgomery, R. R., Tamaki, S. J., Sigdel, T. K., Sarwal, M. M., Lanier, L. L., Tian, Y., Kim, C., Hinz, D., … Rahman, A. H. (2019). A Modified Injector and Sample Acquisition Protocol Can Improve Data Quality and Reduce Inter-Instrument Variability of the Helios Mass Cytometer. Cytometry. Part A : the journal of the International Society for Analytical Cytology95(9), 1019–1030. https://doi.org/10.1002/cyto.a.23866

Leiter, A., Gnjatic, S., Fowkes, M., Kim-Schulze, S., Laface, I., Galsky, M. D., & Gallagher, E. J. (2020). A COMMON PITUITARY AUTOANTIBODY IN TWO PATIENTS WITH IMMUNE CHECKPOINT INHIBITOR-MEDIATED HYPOPHYSITIS: ZCCHC8. AACE clinical case reports6(4), e151–e160. https://doi.org/10.4158/ACCR-2019-0585

Li, S., Sun, J., Allesøe, R., Datta, K., Bao, Y., Oliveira, G., Forman, J., Jin, R., Olsen, L. R., Keskin, D. B., Shukla, S. A., Wu, C. J., & Livak, K. J. (2019). RNase H-dependent PCR-enabled T-cell receptor sequencing for highly specific and efficient targeted sequencing of T-cell receptor mRNA for single-cell and repertoire analysis. Nature protocols14(8), 2571–2594. https://doi.org/10.1038/s41596-019-0195-x

Miao, D., Margolis, C. A., Gao, W., Voss, M. H., Li, W., Martini, D. J., Norton, C., Bossé, D., Wankowicz, S. M., Cullen, D., Horak, C., Wind-Rotolo, M., Tracy, A., Giannakis, M., Hodi, F. S., Drake, C. G., Ball, M. W., Allaf, M. E., Snyder, A., Hellmann, M. D., … Van Allen, E. M. (2018). Genomic correlates of response to immune checkpoint therapies in clear cell renal cell carcinoma. Science (New York, N.Y.)359(6377), 801–806. https://doi.org/10.1126/science.aan5951

Moen, E., Bannon, D., Kudo, T., Graf, W., Covert, M., & Van Valen, D. (2019). Deep learning for cellular image analysis. Nature methods16(12), 1233–1246. https://doi.org/10.1038/s41592-019-0403-1

Monjazeb AM, et al. (Trial 10021) A Randomized Trial of Combined PD-L1 and CTLA-4 Inhibition with Targeted Low-Dose or Hypofractionated Radiation for Patients with Metastatic Colorectal Cancer. Clin Cancer Res 2021;27(9). DOI: 10.1158/1078-0432.CCR-20-4632.

Pan, D., Kobayashi, A., Jiang, P., Ferrari de Andrade, L., Tay, R. E., Luoma, A. M., Tsoucas, D., Qiu, X., Lim, K., Rao, P., Long, H. W., Yuan, G. C., Doench, J., Brown, M., Liu, X. S., & Wucherpfennig, K. W. (2018). A major chromatin regulator determines resistance of tumor cells to T cell-mediated killing. Science (New York, N.Y.)359(6377), 770–775. https://doi.org/10.1126/science.aao1710

Patel SS and Rodig SJ. Overview of Tissue Imaging Methods. Methods Mol Biol (2020);2055:455-465.  PMID: 31502165. In: Thurin M, Cesano A, Marincola FM (Eds.).Biomarkers for Immunotherapy of Cancer: Methods and Protocols. Springer Nature.

Penter L, et al. Local and Systemic Effects of Immune Checkpoint Blockade on Relapsed Myeloid Malignancies Following Allogeneic Hematopoietic Stem Cell Transplantation (poster abstract, ASH 2020). https://ash.confex.com/ash/2020/webprogram/Paper139487.html

Penter L, et al. (Trial 9204) Molecular and cellular features of CTLA-4 blockade for relapsed myeloid malignancies after transplantation. Blood 2021 Jun 10;137(23):3212-3217. doi: 10.1182/blood.2021010867.

Rahman, A., et al. CIMAC-CIDC CyTOF harmonization. J Clin Oncol (2020);38:15s (suppl; abstr e15242) https://ascopubs.org/doi/abs/10.1200/JCO.2020.38.15_suppl.e15242

Sahaf B, et al. Multi-Center Immune Profiling Mass Cytometry Assay Harmonization. Clin Cancer Res. 2021 Jul 15;clincanres.CCR-21-2052-A.2021. doi: 10.1158/1078-0432.CCR-21-2052.

Sahaf, B., Rahman, A., Maecker, H. T., & Bendall, S. C. (2020). High-Parameter Immune Profiling with CyTOF. Methods in molecular biology (Clifton, N.J.)2055, 351–368. https://doi.org/10.1007/978-1-4939-9773-2_16

Salmon, H., Remark, R., Gnjatic, S., & Merad, M. (2019). Host tissue determinants of tumour immunity. Nature reviews. Cancer19(4), 215–227. https://doi.org/10.1038/s41568-019-0125-9

Sarkizova, S., Klaeger, S., Le, P. M., Li, L. W., Oliveira, G., Keshishian, H., Hartigan, C. R., Zhang, W., Braun, D. A., Ligon, K. L., Bachireddy, P., Zervantonakis, I. K., Rosenbluth, J. M., Ouspenskaia, T., Law, T., Justesen, S., Stevens, J., Lane, W. J., Eisenhaure, T., Lan Zhang, G., … Keskin, D. B. (2020). A large peptidome dataset improves HLA class I epitope prediction across most of the human population. Nature biotechnology38(2), 199–209. https://doi.org/10.1038/s41587-019-0322-9

Schoenfeld JD, et al. Durvalumab plus tremelimumab alone or in combination with low-dose or hypofractionated radiotherapy in metastatic non-small-cell lung cancer refractory to previous PD(L)-1 therapy: an open-label, multicentre, randomised, phase 2 trial. Lancet Oncol. 2022 Jan 13;S1470-2045(21)00658-6. doi: 10.1016/S1470-2045(21)00658-6. PMID: 35033226.

Thompson RC, et al. Acute COVID-19 gene-expression profiles show multiple etiologies of long-term sequelae. medRxiv [Preprint]. 2021 Oct 5:2021.10.04.21264434.
doi: 10.1101/2021.10.04.21264434. PMID: 34642700; PMCID: PMC8509101.

Tsai, A. G., Glass, D. R., Juntilla, M., Hartmann, F. J., Oak, J. S., Fernandez-Pol, S., Ohgami, R. S., & Bendall, S. C. (2020). Multiplexed single-cell morphometry for hematopathology diagnostics. Nature medicine26(3), 408–417. https://doi.org/10.1038/s41591-020-0783-x

Wistuba I, et al.  Cross-site concordance evaluation for the CIMAC-CIDC network to establish QC metrics enabling reliable generation of WES and RNA-seq data. J Clin Oncol (2020);38:15s (suppl; abstr e15240). https://ascopubs.org/doi/abs/10.1200/JCO.2020.38.15_suppl.e15240?af=R&

Zeng Z, et al. Cross-site concordance evaluation of tumor DNA and RNA sequencing platforms for the CIMAC-CIDC network. Clin Cancer Res 2021; doi: 10.1158/1078-0432.CCR-20-3251.

Zhang, J., Hu, X., Wang, J., Sahu, A. D., Cohen, D., Song, L., Ouyang, Z., Fan, J., Wang, B., Fu, J., Gu, S., Sade-Feldman, M., Hacohen, N., Li, W., Ying, X., Li, B., & Liu, X. S. (2019). Immune receptor repertoires in pediatric and adult acute myeloid leukemia. Genome medicine11(1), 73. https://doi.org/10.1186/s13073-019-0681-3

Zhou, J., Li, J., Guleria, I., Chen, T., Giobbie-Hurder, A., Stevens, J., Gupta, M., Wu, X., Brennick, R. C., Manos, M. P., & Hodi, F. S. (2019). Immunity to X-linked inhibitor of apoptosis protein (XIAP) in malignant melanoma and check-point blockade. Cancer immunology, immunotherapy : CII68(8), 1331–1340. https://doi.org/10.1007/s00262-019-02370-4